H7N9 avian influenza virus lysis adjuvant vaccine (Tianyuan bio-pharm)

H7N9禽流感病毒裂解佐剂疫苗（浙江天元生物）

Report date: 2022/07/15 15:12:27

Base Information

Drug NameH7N9 avian influenza virus lysis adjuvant vaccine (Tianyuan bio-pharm)
Drug Alias NameN/A
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza in Birds
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesZhejiang Tianyuan Bio-Pharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesZhejiang Tianyuan Bio-Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza in Birds
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A